跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 204 条关于
“FGF21R”
全部
204
临床试验
163
药物
21
机构
0
资讯
20
去年
Doer Biologics Completes Phase 2 Enrollment for Novel Tri-Specific Agonist Targeting Severe Hypertriglyceridemia
去年
Doer Bio Doses First Patient in Phase 2 Trial of DR10624 for Severe Hypertriglyceridemia
去年
Novel Pipeline Drugs Show Promise in Treating Severe Hypertriglyceridemia
3个月前
Single-Dose AAV-FGF21 Gene Therapy Extends Health Span by 20.54% in Aged Mice
3个月前
Alcohol May Trick the Brain Into Craving Junk Food via the Hormone FGF21, Study Suggests
10个月前
FGF18 Emerges as Promising Therapeutic Target for Post-Traumatic Osteoarthritis Through FOXN2 Pathway
去年
Tyra Biosciences' FGFR3 Inhibitor TYRA-300 Shows Promise in Urothelial Cancer
去年
Rogaratinib Plus Atezolizumab Shows Promise in FGFR mRNA-Overexpressing Urothelial Cancer
11年前
Tyra Biosciences Advances FGFR Inhibitor Pipeline with Multiple Clinical Trials
去年
FDA Approves Pemigatinib for Rare FGFR1-Rearranged Myeloid/Lymphoid Neoplasms Following Stanford-Led Phase II Trial
第 1 页,共 2 页
上一页
下一页